Home > News > PSivida lifts pSiMedica stake to 100%
June 1st, 2004
PSivida lifts pSiMedica stake to 100%
Nanotechnology firm pSivida Ltd has acquired full ownership of its United Kingdom subsidiary pSiMedica Ltd for $57.8 million in scrip and cash. PSivida said the full ownership of pSiMedica would enhance the rate of development of its BioSilicon technology and lift pSivida's appeal to institutional investors. PSivida will acquire the pSiMedica shares it does not already own from its joint venture partner in pSiMedica, QinetiQ plc, and other minority shareholders.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014